Delivery Order SPE2DB20D2014-SPE2DB24FC24H
Award Date
6/13/24
Potential Completion Date
6/14/24
Potential Value
$27K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,292.00 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a completion date of February 28, 2025. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA). The $4,204.24 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. The contract is a delivery order off of an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The federal contract award described is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,860.62 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 10, 2025, with a completion date of January 13, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical...
The federal contract award details the procurement of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML by the Defense Logistics Agency (DLA), a defense agency. The $12,016.70 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with a completion date of January 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $3,056.62 firm fixed price contract was awarded on June 10, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a completion date of June 11, 2024. The contract is not set aside for a specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication for the treatment of diabetes, to the Defense Logistics Agency (DLA). The $1,877.15 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 9, 2022 with an ultimate completion date of July 10, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,711.03, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 31, 2024. This contract award is not designated as a set-aside and is part of a larger...
The federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 ml to the Defense Logistics Agency (DLA). The $17,149.58 Firm Fixed Price contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $10,498.49. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 31, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The $7,177.37 firm fixed price contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, on June 27, 2024, with a completion date of June 28, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...